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ABSTRACT Activation of the AP-1 complex of transcrip-
tion factors is one of the earliest nuclear responses to mitogenic
stimuli. We demonstrate directly that AP-1 activity is required
for human cells to proliferate in response to serum. We also
find that activity of the AP-1 complex is selectively reduced in
old human fibroblasts prior to their entering a fully senescent
state. Levels of Fos protein induced through diverse signal
transduction pathways, the amount of AP-1 DNA binding
activity in vitro, and the activity of an AP-1-dependent reporter
gene in vivo are substantially decreased as fibroblasts age.
Moreover, the composition of the AP-1 complex changes, so
that old cells produce predominantly Jun-Jun homodimers
instead ofFos-Jun heterodimers. Changes in AP-1 activity may
be due in part to changes in posttranslational modification of
Fos protein that impair its ability to form active DNA-binding
heterodimers with Jun These data suggest that changes in
AP-1 activity may contribute to the inability of senescent cells
to proliferate in response to mitogens.
Human diploid fibroblasts (HDFs) undergo a finite number of
population doublings in vitro (1), which is inversely propor-
tional to the age of the donor. This observation and the direct
correlation seen between the maximum life span of animal
species and the replicative life span of their fibroblasts
cultured in vitro (2) suggest that mechanisms underlying HDF
senescence in vitro may play a role in the decline of many
functions seen during aging in vivo (for a review, see ref. 3).
Senescent HDFs are unable to proliferate in response to
normally mitogenic extracellular stimuli and appear to be
blocked within the G1 phase of the cell cycle (4, 5). Because
growth factor receptors generally appear to be functional in
senescent HDFs (6), the block to proliferation apparently lies
between the stimulation of membrane receptors and the
initiation of S phase.
Expression of several cellular genes including c-fos (7-9),
c-Ha-ras (10), and c-myc (11, 12) is required for cells to
progress through the G1 phase of the cell cycle and enter into
DNA synthesis. But expression of these and other cell-cycle-
regulated genes is not appreciably reduced in senescent cells
(13), with one reported exception, that of c-fos (14). c-fos is
a particularly attractive candidate as a control point for cell
proliferation since it encodes a transcription factor with the
potential to regulate events later in progression through GU.
Fos is a member of a family of transcription factors that
contain highly conserved positively charged DNA-binding
domains and leucine-zipper motifs. Fos proteins act in het-
erodimeric complexes with members of the Jun family of
protooncogenes by binding to specific regulatory elements
termed AP-1 sites (for review, see ref. 15). We show here that
AP-1-binding factors constitute a control point for G1 pro-
gression by selectively inactivating AP-1-binding factors in
living cells. Moreover, we show that as cells begin to age they
show a striking decline in AP-1 activity. We suggest that AP-1
activity may be one of the major molecular defects respon-
sible for the decline in the proliferative response to mitogens
seen during cellular senescence.
MATERIALS AND METHODS
Cell Culture and Emulsion Autoradiography. Human Hs68
fibroblasts (American Type Culture Collection CRL 1635)
were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 1 mM glutamine and 10% (vol/
vol) fetal bovine serum (FBS). Young, old, and senescent
fibroblasts were tested in parallel with other experiments for
their ability to synthesize DNA by emulsion autoradiography
using Kodak nuclear track emulsion as described (9).
Microinjection and Immunocytochemistry. Microinjection
and visualization of cells was as described (9). Synthetic
double-stranded oligodeoxynucleotides used in all assays
contained a single copy of a wild-type AP-1 site (5'-
TCGACGGTATCGATAAGCTATGACTCATCCGGGG-
GATC-3') or a mutant site (5'-TCGACGGTATCGATAAGC-
TATAAGTTATCCGGGGGATC-3'). Oligonucleotides were
injected at 0.3 mg/ml with nonspecific rabbit IgG at 0.5
mg/ml. Fixation and staining with rabbit anti-Fos and anti-
f3-galactosidase was as described (9). Micrographs in Figs. 3
and 4 were taken using identical exposure and printing
conditions to allow direct comparison.
DNA Affinity Precipitation Assays. Radiolabeled cells were
harvested in phosphate-buffered saline (PBS) containing
0.1% Nonidet P-40 (1 ml per 10-cm plate). Nuclei were
pelleted 15 sec at 40C at 12,000 x g, and buffer was aspirated.
Proteins were extracted in 4 vol of high-salt buffer (20 mM
Hepes, pH 7.9/400 mM KCl/10 mM NaF/0.5 mM MgSO4/1
mM EDTA/1 mM dithiothreitol/1 mM aprotinin/1 mM leu-
peptin/1 mM pepstatin) for 30 min on ice. Nuclei were
pelleted 10 min at 4°C as above; the supernatants were
recovered, and DNA affinity precipitation assays were per-
formed as described (16) with minor modifications. Extracts
containing equal amounts of incorporated 35S were incubated
30 min at 20°C with either 0.5 ,g of biotinylated wild-type
oligonucleotides or 0.5 ,g of mutant oligonucleotides de-
scribed above. Binding products were recovered with strepa-
vidin-agarose beads, washed, boiled in sample buffer, and
electrophoresed through 12.5% denaturing polyacrylamide
gels. Gels were fixed, impregnated with 1 M salicylate, and
fluorographed at -80°C for 48 hr.
Abbreviations: HDF, human diploid fibroblast; MPD, mean popu-
lation doubling; FBS, fetal bovine serum; PMA, phorbol 12-
myristate 13-acetate.
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Metabolic Labeling and Immunoprecipitation. Young, old,
and senescent cells were grown to 75% confluence and
deprived of serum for 48 hr prior to refeeding with methio-
nine-free DMEM containing [35S]methionine at 0.3 mCi/ml (1
Ci = 37 GBq). After stimulation, cells were washed with PBS
and harvested on ice in RIPA buffer (20 mM Tris-HCl, pH
7.5/100 mM NaCI/5 mM KCI/1 mM EDTA/0.25% deoxy-
cholate/0.25% Nonidet P-40/0.25% Tween 20). Lysates were
sonicated, pelleted at 4°C for 2 min, and preadsorbed with
protein A-Sepharose for 30 min at 4°C. Samples ofeach lysate
containing identical amounts of 35S were incubated with
excess Fos or Jun antibody for 2 hr at 4°C with rocking.
Antibody-antigen complexes were recovered on protein
A-Sepharose beads, washed five times in ice-cold RIPA
buffer, and boiled in sample buffer prior to one- or two-
dimensional gel electrophoresis (17).
RESULTS
Microinjection of Excess AP-1-Binding Sites Blocks DNA
Synthesis in Response to Growth Factors. Introduction of
double-stranded oligonucleotides containing sequences cor-
responding to regulatory elements in the c-fos gene blocks
c-fos induction by extracellular stimuli, presumably by titra-
tion of the endogenous transcription factors required for
these responses (18, 19). Thus, microinjection of oligonucle-
otides containing a consensus AP-1 binding site should ef-
fectively compete for proteins required for transcriptional
activation of genes containing these sites, neutralizing cellu-
lar AP-1 activity. To test whether AP-1 activity was required
to traverse G1, AP-1 oligonucleotides (0.3 mg/ml) and non-
specific rabbit IgG (0.5 mg/ml) were mixed and microinjected
into quiescent serum-deprived young HDFs. Cells were refed
with medium containing 10%o FBS and [3H]thymidine (2
ttCi/ml). Thirty-six hours after refeeding, cells were fixed,
stained for IgG to identify injected cells (9, 20), and coated
with nuclear track emulsion to identify cells that had initiated
DNA synthesis. Injection of nonspecific antibodies has no
detectable effects on DNA synthesis (20). Approximately
80%o of uninjected cells incorporated [3H]thymidine in 36 hr
(Fig. 1A), whereas none ofthe cells injected with a consensus
AP-1 oligonucleotide (stained cells in Fig. 1B) initiated DNA
synthesis during this period. This was not due to nonspecific
effects of oligonucleotide microinjection, since cells injected
with the same concentration of a mutant oligonucleotide
identical at 35 of 38 base pairs were not prevented from
synthesizing DNA in response to serum stimulation (Fig.
1C). In three experiments, an average of 82% of the unin-
jected cells (123 of 150 cells), 4% of the cells injected with the
AP-1 oligonucleotide (7 of 172 cells), and 70% of the cells
injected with a control oligonucleotide (102 of 146 cells)
incorporated [3H]thymidine. These results suggest that pro-
teins that bind specifically to this AP-1 site are required for
initiation of DNA synthesis.
In Vitro AP-1-Binding Activity Is Markedly Reduced in Old
Fibroblasts. To characterize the proteins that bound the AP-1
oligonucleotides used in the microinjection experiments and
to determine whether there were changes in these proteins as
the cells aged in vitro, we performed DNA affinity precipi-
tation assays (16) using [35S]methionine-labeled nuclear pro-
tein extracts from serum-stimulated young [mean population
doublings (MPD) = 42] and old (MPD = 77) fibroblasts (Table
1). As shown in Fig. 2, the wild-type AP-1 probe bound large
amounts of Fos and Jun proteins in young cells; this is a
specific interaction, because the proteins were not recovered
with the mutant probe. In contrast, the wild-type probe
recovered virtually no detectable Fos protein from the old
cells, and the quantity of Jun bound was reduced by about
half. This suggests that there is a significant change in the
amount and composition of cellular AP-1 binding proteins in
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FIG. 1. Microinjection of wild-type and mutant AP-1 oligodeox-
ynucleotides. Young (MPD = 38) Hs68 fibroblasts injected with
wild-type (B) or mutant (C) AP-1 oligonucleotides were tested for
their ability to synthesize DNA after serum-stimulation by [3H]thy-
midine incorporation followed by emulsion autoradiography. (A)
Uninjected cells. Cytoplasmic staining marks injected cells. (Bar =
50 ,um.)
old cells. Because the DNA affinity precipitation assays are
performed at high oligonucleotide concentration, this assay
detects relatively low-affinity protein-DNA interactions and,
therefore, probably underestimates the reduction in effective
AP-1 binding activity in the old cells. Consistent with this
Table 1. Proportion of cells incorporating [3H]thymidine at
various passages
% labeled nuclei
Cells Passage - serum + serum
Young 38 7 87
40 11 80
42 8 82
Old 76 6 24
77 8 21
78 5 19
Senescent 80 2 5
Cells deprived of serum for 48 hr were grown in medium containing
[3H]thymidine (2 1LCi/ml) in the presence or absence of10o FBS for
36 hr. Cells were fixed, coated with nuclear track emulsion, and
developed 4 days later, and fields of 200 cells were visually scored
for incorporation of [3H]thymidine (9). Cells for all experiments were
subcultured within 1 day ofreaching confluence at ratios of 1:1 to 1:8.
Young fibroblasts were typically from 30 to 45 MPDs and old
fibroblasts were from 75 to 78 MPDs. Senescent fibroblasts required
20 days to achieve 75% confluence after a final 1:2 subculturing.
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FIG. 2. DNA affinity precipitation assay of AP-1 binding proteins
in young and old fibroblasts. Young (lanes Y, MPD = 42) and old
(lanes 0, MPD = 77) Hs68 fibroblasts were deprived of serum for 48
hr, refed with medium containing 1o FBS and [35S]methionine (0.5
mCi/ml), and incubated for 90 min. Nuclear extracts were prepared
and incubated with 0.5 ,g of biotinylated wild-type (lanes wt) or
mutant (lanes mu) AP-1 oligonucleotides. Bound proteins were
recovered with streptavidin-agarose beads and analyzed by electro-
phoresis on a 12.5% polyacrylamide gel followed by fluorography.
conclusion, we observe an =10-fold reduction in serum-
stimulated AP-1 activity as measured in mobility-shift assays
(data not shown).
AP-1 Transcriptional Activity in Intact Cells Decreases
During Aging. The reduction in AP-1 DNA-binding activity
that accompanies cellular aging suggests that transcription of
AP-1-dependent genes is reduced in old cells. To test this
hypothesis, we microinjected individual young (MPD = 46)
and old (MPD = 76) cells with a lacZ reporter gene (0.5
mg/ml) under the control of four tandem AP-1 sites. Six
hours after injection, cells were refed with medium contain-
ing or lacking phorbol 12-myristate 13-acetate (PMA; 100
ng/ml), incubated for 2 hr, and fixed for indirect immuno-
fluorescence staining. As shown in Fig. 3, expression of
p-galactosidase was low in unstimulated young fibroblasts
and undetectable in unstimulated old fibroblasts. PMA in-
Young Old
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duced high levels of expression in young fibroblasts and
considerably lower levels in old fibroblasts. Although we are
unable to measure quantitatively the fluorescence intensities
in these cells, the differences between the young and old
cells, relative to the consistent background staining in all
fields, were highly reproducible in several experiments.
Thus, we conclude that transcription of AP-1-dependent
genes is impaired in old cells.
Expression of Fos Protein Is Reduced in Aging Human
Fibroblasts. Since the DNA precipitation assays suggested
that reduced AP-1 activity in old fibroblasts may be due to
decreased binding of Fos, we asked whether Fos protein
levels were reduced in old cells. Young (MPD = 42) and old
(MPD = 76) serum-deprived fibroblasts were refed with
complete medium, fixed 90 min later, and stained for the
presence of Fos. Young and old fibroblasts contained very
low levels of protein reactive with Fos antibody prior to
serum stimulation (Fig. 4 A and B). After stimulation, Fos
protein rose to much higher levels in young compared to old
fibroblasts (compare Fig. 4 C and D). Similar results were
seen in two other human fibroblast lines, HF and A2 (data not
shown). Thus, the amount of protein reactive with our Fos
antiserum is reduced in old cells.
To corroborate this observation, we performed immuno-
precipitation analysis using young, old, and senescent cells
(Table 1). Serum-deprived fibroblasts were stimulated with
various agents in the presence of [35S]methionine and har-
vested 90 min later for immunoprecipitation analysis. Fig. 5
shows that young cells expressed much higher levels of Fos
than old or senescent fibroblasts in response to cAMP, PMA,
serum, or platelet-derived growth factor. Fos induction was
impaired in old cells in response to all of the stimuli tested,
even though they act through several different cis-acting
elements in the c-fos promoter. Furthermore, these results
also indicate that Fos synthesis was decreased to similar
extents in old and senescent cells, despite a 4- to 5-fold higher
proliferation rate in the former cultures. Thus, Fos synthesis
levels fall as proliferation potential declines, not after entry
into a fully senescent state.
We next did a time-course experiment to measure the
levels of Fos and Jun expression in serum-stimulated cells
and the extent to which the proteins formed heterodimers.
[35S]Methionine was added at various times after stimulation,
1 hr prior to harvesting. Lysates were prepared under non-
denaturing conditions and diluted to contain equal amounts of
incorporated 35S. Half of each lysate was immunoprecipi-
+PMA
FIG. 3. In vivo AP-1 activity in young (Left) and old (Right)
fibroblasts. Hs68 cells were microinjected with a plasmid containing
the Escherichia coli lacZ gene downstream offour tandemly repeated
AP-1 sites. Cells were left untreated (Upper) or were treated with
PMA (100 ng/ml) (Lower). The cells were fixed and stained for
,B-galactosidase, mounted, and photographed. (x 1360.)
FIG. 4. Inducible expression of Fos protein in young and old
fibroblasts. Fibroblasts grown on glass coverslips for 3 days were
deprived of serum for 48 hr, refed with medium containing 10o FBS,
fixed 90 min later, and processed for indirect immunofluorescence
using rabbit anti-Fos as primary antibody. (A) Unstimulated young
cells. (B) Unstimulated old cells. (C) Stimulated young cells. (D)
Stimulated old cells. (x 1440.)
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FIG. 5. Immunoprecipitation of Fos from stimulated and unstim-
ulated young, old, and senescent fibroblasts. Young (lanes Y, MPD
= 40), old (lanes 0, MPD = 76), and senescent (lanes S, MPD = 80)
fibroblasts deprived of serum for 48 hr and at a density of 75% of
confluence were refed with medium containing [35S]methionine (0.3
mCi/ml) plus 0.5 mM isobutylmethylxanthine and 10,uM forskolin,
which increases intracellular levels of cAMP (lanes IF); PMA (100
ng/ml); 10% FBS (lanes Ser); or platelet-derived growth factor (lanes
PDGF, 10 ng/ml). Unstimulated cells are in lanes -Stim. Immuno-
precipitations were done with an affinity-purified polyclonal anti-
body under nondenaturing conditions. Similar results were obtained
using a monoclonal antibody (TF-161) that recognizes Fos. The
sample containing Fos immunoprecipitated from serum-stimulated
senescent cells was lost during preparation. In subsequent experi-
ments levels of Fos in old and senescent serum-stimulated cells were
very similar. Bands identified as Fos and Jun were specifically lost
when control immunoprecipitations were done in the presence of
excess unlabeled bacterially expressed Fos fusion protein (data not
shown). MW, molecular size standards (kDa).
tated with Fos antibodies (Fig. 6A) and half was immuno-
precipitated with Jun antibodies (Fig. 6B). Old fibroblasts
synthesized much lower amounts of Fos protein than young
fibroblasts when quiescent (Fig. 6A, lanes 1 and 2) or during
the first (lanes 3 and 4) or second (lanes 5 and 6) hour ofserum
stimulation. In young cells, a fraction of the newly synthe-
sized Fos protein was recovered in complexes with Jun
protein within 1 hr of stimulation (Fig. 6B, lane 3) when using
antibodies directly recognizing Jun. In contrast, Jun antibod-
ies did not coprecipitate detectable amounts of Fos protein
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from old fibroblasts (Fig. 6B, lane 4). This is largely due to
reduction in total Fos protein concentration in the old cells.
But, although some Fos protein is synthesized by these cells
(Fig. 6A, lane 4), we observe none either in complex with Jun
(Fig. 6B, lane 4) or in active AP-1-binding complexes (Fig. 2).
Therefore, we suggest that the Fos protein synthesized in old
cells may be impaired in its ability to form active het-
erodimeric DNA-binding complexes with Jun.
Fos Protein Is Modified Differently in Young and Old
Fibroblasts. To test the hypothesis that the Fos protein
synthesized in old cells differs from that produced by young
cells, we analyzed immunoprecipitated Fos by high-
resolution two-dimensional gel electrophoresis. Fig. 7 shows
that Fos was resolved into at least seven isoforms in young
cells stimulated with serum or cAMP. In old cells only some
ofthe isoforms were seen, with those labeled 1-4 being barely
detectable or completely absent. Old serum-stimulated cells
contained two other isoforms (labeled 8 and 9) at more acidic
isoelectric points, and old cAMP-stimulated cells showed
only one major isoform (labeled 5) and barely detectable
amounts of isoforms labeled 1 and 4. Thus, in addition to
expressing lower amounts of Fos in response to stimulation,
the Fos protein expressed by old fibroblasts is modified to
produce a smaller number of more acidic (and presumably
more highly phosphorylated) isoforms. These modified forms
of Fos may differ in their ability to form heterodimers with
Jun or to bind DNA.
DISCUSSION
This study shows that AP-1 activity is required in primary
human fibroblasts for the initiation of DNA synthesis in
response to serum. Since Fos is a major constituent of the
proteins that bind specifically to the oligonucleotide microin-
jected (Fig. 2), the previously described requirement for Fos
during mitogen-induced growth (7-9) is likely due to partici-
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FIG. 6. Time course of Fos and Jun expression. Young (lanes Y)
and old (lanes 0) fibroblasts deprived of serum for 48 hr were
pulse-labeled for 1 hr in [35S]methionine medium lacking (lanes 1 and
2) or containing (lanes 3-6) 10%o FBS. Cells were labeled before
addition of serum (0 hr) or during the first (1 hr) or second (2 hr) hour
of serum stimulation. Lysates containing equal amounts of incorpo-
rated [35S]methionine were immunoprecipitated with Fos antibodies
(A) or with Jun antibodies (B), electrophoresed, and fluorographed as
in Fig. 5. Bands labeled Fos and Jun were not recovered when Jun
antibodies were preincubated with unlabeled bacterially expressed
Jun protein (data not shown).
FIG. 7. Old fibroblasts lack isoforms of Fos seen in young
fibroblasts. Lysates from young (MPD = 42) (Left) and old (MPD =
78) (Right) fibroblasts were prepared and immunoprecipitated as
described in Fig. 5. (Upper) Cells were refed with medium containing
10% FBS. (Lower) Cells were refed with medium containing 0.5 mM
isobutylmethylxanthine and 10 1tM forskolin. Immunoprecipitation
products were resolved on high-resolution two-dimensional gels as
described (17). All immunoprecipitations contained equal amounts of[35S]methionine. Total immunoprecipitation products were electro-
phoresed on high-resolution two-dimensional gels except for young
cells stimulated with serum in which only 25% of the immunopre-
cipitation product was electrophoresed to allow resolution of Fos
isoforms. Left to right corresponds to acidic to basic and top to
bottom corresponds to lower to higher electrophoretic mobility in the
denaturing second dimension. Isoforms are labeled 1-9.
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pation ofFos in a DNA-bound transcription complex. We also
determined that AP-1 activity was decreased significantly in
old and senescent fibroblasts. This observation contrasts with
generally modest (up to 2-fold) differences seen in other
cellular properties during aging, including amounts of Oct-1
binding activity (data not shown), levels ofDNA methylation
(21), translocation of protein kinase C (31), size and number of
extrachromosomal DNA elements (23), length of telomere
sequences (24), rate ofDNA replication (25), and the expres-
sion of 11 growth-related genes excluding c-fos (13).
Old cells that displayed decreased AP-1 activity in vitro
and in vivo were not fully senescent. They were still capable
ofa limited number ofcell divisions, but at a severely reduced
growth rate reflected by a 3.5-fold decrease in the number of
cells incorporating [3H]thymidine over a 36-hr period (Table
1). The fact that AP-1 activity decreased during the onset of
proliferative decline in these cells, rather than when cells
became fully senescent, suggests a critical connection be-
tween decreased AP-1 activity and the ability offibroblasts to
proliferate in culture.
Decreased AP-1 activity could be due to reduced expres-
sion of components of the AP-1 complex or to production of
dominant inhibitors that block the DNA-binding or transcrip-
tional activity of the complex. Our data are most consistent
with reduced synthesis coupled with altered posttranslational
processing of the Fos protein. Reduced synthesis of Fos
protein is likely due to a reduction in c-fos gene transcription
as reported for another primary human cell line (14). Al-
though our data do not directly address the mechanism of this
reduction, reduced Fos protein synthesis in response to
several stimuli that act through diverse regulatory elements
in the c-fos promoter (15) suggests that a generalized repres-
sion of c-fos transcription, perhaps due to expression of a
dominant inhibitor, rather than selective loss of inducing
signals, is responsible for reduced Fos synthesis. This model
is consistent with observations suggesting dominance of the
senescent phenotype (22, 26).
One such inhibitor might be the product of the retinoblas-
toma (Rb) gene. Rb, which is a growth suppressor gene (27),
inhibits the expression of reporter genes driven by a c-fos
promoter (28) and is not phosphorylated in senescent IMR-90
fibroblasts in response to serum addition (29). In contrast, we
did not see changes in the expression or phosphorylation
state of Rb or p53 immunoprecipitated from young and old
Hs68 fibroblasts, even though these cells showed large dif-
ferences in their ability to express Fos. However, in subse-
quent experiments we have seen decreased phosphorylation
of Rb in fully senescent Hs68 cells (data not shown) as
reported for IMR-90 fibroblasts, but only several MPDs later
than initial decreases in Fos expression. Since phosphoryla-
tion ofRb begins at the onset ofDNA synthesis, well after the
early to mid-G1 requirement for Fos for entry into S phase (9),
decreased phosphorylation ofRb may be secondary to loss of
AP-1 activity and subsequent inability of cells to traverse G1.
In addition to the decrease in overall AP-1 activity, the
selective reduction in Fos synthesis means that there is a
significant change in the composition of residual AP-1 com-
plexes in aging and senescent cells. This change in compo-
sition is potentially very important in the light of recent
reports that AP-1 proteins interact with other transcription
factors and that Fos-Jun heterodimers can differ in activity
from Jun-Jun homodimers (30).
These data provide a clear example ofa change in a specific
transcriptional activity during in vitro aging in fibroblasts.
They also suggest, but do not prove, that changes in AP-1
activity might be responsible for the inability of normal
diploid fibroblasts to replicate indefinitely. One way to ad-
dress this question would be to establish cell lines that
express higher levels of Fos in a regulated manner and then
determine if these lines would proliferate longer than naive
parental lines. However, since AP-1 activity is due to the
protein products of at least two gene families, and our data
indicate that Fos is posttranslationally modified to different
extents during in vitro aging, evaluation of such experiments
may not be straightforward. An approach that may prove
more productive is to identify more of the regulatory proteins
that control Fos expression.
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